Abstract
The vasoactive peptide urotensin-II and its receptor, GPR14 (now known as UT receptor), are localised in the mammalian central nervous system. Accordingly, various centrally mediated effects of urotensin-II on behaviour, neuroendocrine hormones and neurochemistry have been described. To investigate neuroanatomical substrates for the central actions of urotensin-II, expression of the immediate early gene c-fos was examined following intracerebroventricular administration to rats. Urotensin-II increased Fos expression in the cingulate cortex and periaqueductal grey, suggesting important central roles for urotensin-II and its receptor.
Copyright 2004 Elsevier B.V.
MeSH terms
-
Animals
-
Dose-Response Relationship, Drug
-
Gene Expression / drug effects
-
Gene Expression / genetics
-
Gyrus Cinguli / drug effects
-
Gyrus Cinguli / physiology
-
Injections, Intraventricular
-
Ligands*
-
Male
-
Midline Thalamic Nuclei / drug effects
-
Midline Thalamic Nuclei / physiology
-
Neuropeptides / chemistry
-
Neuropeptides / pharmacology*
-
Periaqueductal Gray / drug effects
-
Periaqueductal Gray / physiology
-
Proto-Oncogene Proteins c-fos / genetics*
-
Proto-Oncogene Proteins c-fos / immunology
-
Proto-Oncogene Proteins c-fos / metabolism*
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, G-Protein-Coupled / drug effects*
-
Receptors, G-Protein-Coupled / physiology
-
United Kingdom
-
Urotensins / chemistry
-
Urotensins / pharmacology*
Substances
-
Ligands
-
Neuropeptides
-
Proto-Oncogene Proteins c-fos
-
Receptors, G-Protein-Coupled
-
Urotensins
-
Uts2r protein, rat
-
urotensin II